BMJ22h
Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression
1 University of Leeds Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK Background The human enthesis conventional T cells are poorly characterised. Objectives To study the biology ...
BMJ1d
Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands Professor R Landewé, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical ...
BMJ2d
Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis
Correspondence to Dr Tristan Maerz, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA; tmaerz{at}med.umich.edu Objectives Synovium is acutely affected following joint ...
BMJ2d
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis
3 The Japan Agency for Medical Research and Development–Core Research for Evolutional Science and Technology (AMED–CREST), Japan Correspondence to Assistant Professor Satoshi Nojima, Department of ...
BMJ3d
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
Objective: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With recent therapeutic advances, this is now a goal for treatment and may represent a measure to compare ...
BMJ3d
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Objectives To assess the efficacy and safety of abatacept, a selective T-cell costimulation modulator, in a phase III study in psoriatic arthritis (PsA). Methods This study randomised patients (1:1) ...
BMJ4d
EULAR recommendations for patient education for people with inflammatory arthritis
19 Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands Correspondence to Dr Heidi A Zangi, National Advisory Unit on Rehabilitation in ...
BMJ7d
Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis
Objective To synthesise, quantify and compare risks for incident myocardial infarction (MI) across five major types of arthritis in population-based studies. Methods A systematic search was performed ...
BMJ9d
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
Objectives Fatigue is a frequent symptom in rheumatoid arthritis (RA) and has high impact on quality of life. We explored associations between disease activity and fatigue in patients with early RA ...
BMJ10d
Update of EULAR recommendations for the treatment of systemic sclerosis
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...
BMJ16d
Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
Objective This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with ...
BMJ21d
Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis
Correspondence to Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1, New Zealand; n.dalbeth{at}auckland.ac.nz Objectives To ...